You searched for "inflammatory"
St John of Jerusalem Eye Hospital receives recognition and support
7 February 2020
In 2017 the St John Ophthalmic Association (SOA) was established by ophthalmic practitioners across the world to support the St John of Jerusalem Eye Hospital Group. The purpose of the Association is to broaden the ophthalmic expertise available to St John and its staff.
Medical Ophthalmological Society (MOSUK) Meeting: 22 March 2023
11 January 2023
| Nima John Ghadiri
This year’s meeting takes place on 22 March 2023, and showcases the interdisciplinary breadth of medical ophthalmology.
2018/19 Ophthalmology Honours results announced
13 March 2019
Recipients of the 2018/19 Ophthalmology Honours by Bayer were recognised during a presentation held at BMA House, London.
AI insights lead OSA lecture programme
Ophthalmology’s role at the forefront of many areas of healthcare, providing valuable insights to early disease markers and progression, is to be highlighted on the OSA stand at 100% Optical. Some seven hours of free to attend lectures will provide a vision of the next five years of High Street practice.Boosting key protein in eye cells could prevent age-related vision loss, international team finds
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.ABDO announces groundbreaking therapy for contact lens opticians
1 October 2024
|
novel therapies, contact lens, ABDO, optometry, optician, research, new studies, Omnigen, Omnilenz, NuVision, Andy Hill
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.Effective treatment for rare sight-threatening infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.Vision on the line: Managing orbital trauma in a 30-year-old surgeon after a football injury
Blunt orbital trauma is a common consequence of sports injuries. Although retrobulbar haemorrhage is frequently associated with orbital compartment syndrome (OCS), the severity of clinical signs can outweigh imaging findings. Early recognition and intervention, such as lateral canthotomy and cantholysis...10 daily habits damaging your eyesight and changes you can make to remedy against them
15 March 2023
Following World Glaucoma Day on 12 March this year, it is vital that the longevity of our vision is always a priority. However, many of our daily habits contribute to the onset of glaucoma and vision loss.
